What is Grove Labs?
Operating at the intersection of medical laboratories and advanced imaging centers, Grove Labs has established a distinct market presence. With a workforce of 20 to 49 professionals and annual revenue streams between 5M and 10M, the company serves as a critical node in the diagnostic infrastructure. Their focus on precision and technological integration allows them to address complex clinical requirements, positioning the firm as a vital partner for healthcare providers seeking reliable, data-driven diagnostic outcomes. The company's ability to maintain steady growth while navigating the regulatory complexities of the medical sector highlights its operational maturity and strategic foresight.
How much funding has Grove Labs raised?
Grove Labs has raised a total of $4M across 2 funding rounds:
Angel/Seed
$2.2M
Private Equity
$1.8M
Angel/Seed (2014): $2.2M with participation from Upfront Ventures and Felicis Ventures
Private Equity (2015): $1.8M, investors not publicly disclosed
Key Investors in Grove Labs
Upfront Ventures
A Los Angeles-based venture capital firm specializing in technology businesses, with a focus on SaaS, digital media, and retail innovation to support startup growth.
Felicis Ventures
A Menlo Park-based firm that manages multistage funds, targeting early and growth-stage technology companies across sectors like AI, fintech, and SaaS.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Grove Labs?
With this major enterprise-level funding, Grove Labs is poised to transition into a new phase of scaling and market expansion. The capital will likely be deployed to optimize laboratory workflows, integrate next-generation imaging technologies, and potentially broaden its geographic footprint. As the company moves beyond its initial development stages, the focus will shift toward achieving greater economies of scale and solidifying its reputation as a leader in diagnostic innovation. Investors will be closely monitoring the firm's ability to leverage this liquidity to capture additional market share and drive long-term value in the evolving medical technology ecosystem.
See full Grove Labs company page
